Trial Treatment for Diabetic Peripheral Neuropathy
Season 2, Episode 1098, Nov 25, 09:56 AM
Share
Subscribe
November is Diabetes Awareness Month and with 589 million adults worldwide living with the condition, this number is expect to raise to over 850 million by 2050.
The condition comes with many complications, and with the increased pressure on NHS and healthcare systems worldwide, a new clinical trial could be a major step forward in how diabetic complications are treated.
Joining Paulina on the Happy Hour, is Stanley Kim, Chief Executive Officer & Co-Founder of WinSanTor.
Image shows the RNIB Connect Radio logo. On a white background ‘RNIB’ written in bold black capital letters and underline with a bold pink line. Underneath the line: ‘Connect Radio’ is written in black in a smaller font.
The condition comes with many complications, and with the increased pressure on NHS and healthcare systems worldwide, a new clinical trial could be a major step forward in how diabetic complications are treated.
Joining Paulina on the Happy Hour, is Stanley Kim, Chief Executive Officer & Co-Founder of WinSanTor.
Image shows the RNIB Connect Radio logo. On a white background ‘RNIB’ written in bold black capital letters and underline with a bold pink line. Underneath the line: ‘Connect Radio’ is written in black in a smaller font.